On Tuesday, Cara Therapeutics Inc (NASDAQ: CARA) opened lower -4.79% from the last session, before settling in for the closing price of $0.30. Price fluctuations for CARA have ranged from $0.24 to $1.31 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 115.17% annually for the last half of the decade. With a float of $45.77 million, this company’s outstanding shares have now reached $54.48 million.
In an organization with 55 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 84.43%, operating margin of -944.9%, and the pretax margin is -1099.76%.
Cara Therapeutics Inc (CARA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cara Therapeutics Inc is 16.56%, while institutional ownership is 24.73%. The most recent insider transaction that took place on Nov 04 ’24, was worth 1,064. In this transaction PRESIDENT AND CEO of this company sold 3,668 shares at a rate of $0.29, taking the stock ownership to the 168,768 shares. Before that another transaction happened on Aug 01 ’24, when Company’s PRESIDENT AND CEO sold 4,149 for $0.35, making the entire transaction worth $1,452. This insider now owns 172,436 shares in total.
Cara Therapeutics Inc (CARA) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.59 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.38) by -0.21. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Cara Therapeutics Inc (NASDAQ: CARA) Trading Performance Indicators
Check out the current performance indicators for Cara Therapeutics Inc (CARA). In the past quarter, the stock posted a quick ratio of 4.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.75, a number that is poised to hit -0.38 in the next quarter
Technical Analysis of Cara Therapeutics Inc (CARA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.42 million. That was inferior than the volume of 0.65 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 32.96%. Additionally, its Average True Range was 0.03.
During the past 100 days, Cara Therapeutics Inc’s (CARA) raw stochastic average was set at 27.27%, which indicates a significant increase from 13.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.00% in the past 14 days, which was lower than the 74.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2894, while its 200-day Moving Average is $0.5064. However, in the short run, Cara Therapeutics Inc’s stock first resistance to watch stands at $0.3014. Second resistance stands at $0.3127. The third major resistance level sits at $0.3209. If the price goes on to break the first support level at $0.2819, it is likely to go to the next support level at $0.2737. Assuming the price breaks the second support level, the third support level stands at $0.2624.
Cara Therapeutics Inc (NASDAQ: CARA) Key Stats
There are currently 54,856K shares outstanding in the company with a market cap of 15.91 million. Presently, the company’s annual sales total 20,970 K according to its annual income of -118,510 K. Last quarter, the company’s sales amounted to 2,560 K and its income totaled -12,480 K.
